Amount Raised
$20 Million
Round Type
Series A
New YorkBiotechnologyHealth CareTherapeuticsDescription
New York City-based startup Waypoint Bio has raised $20 million in Series A financing. The funding will be used to test multiple cell therapies in China. This round is aimed at advancing the company's clinical trials.
Quick answer
Waypoint Bio raised $20 Million in a Series A round, dated May 27, 2026. Waypoint Bio is based in New York, New York, United States.
- How much did Waypoint Bio raise?
- Waypoint Bio raised $20 Million in a Series A round on May 27, 2026.
- What does Waypoint Bio do?
- Waypoint Bio is a biotechnology company pioneering novel cell therapies for solid tumors using in vivo spatial pooled screening technology.
- Where is Waypoint Bio based and how big is it?
- Waypoint Bio is based in New York, New York, United States. Fundz records about 21 employees.
- Who are the decision-makers at Waypoint Bio?
- Fundz holds 1 contact at Waypoint Bio, including the Co-founder and CSO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Waypoint Bio that raised within 45 days of this round, from Fundz verified event records.
- Alchemab Therapeutics raised $33M (Series A) on July 8, 2026.
- Allotera Therapeutics raised $35M (Funding Round) on July 8, 2026.
- Respiro Diagnostics raised $1.3M (Pre-Seed) on July 8, 2026.
- Healome Therapeutics raised $2.7M (Seed) on July 7, 2026.
- Cyllene raised $38M (Series C) on July 7, 2026.
- Cyllene Therapeutics raised $38M (Series C) on July 7, 2026.
Who to call at Waypoint Bio, and when
A new round usually means Waypoint Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Waypoint Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Waypoint Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Waypoint Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Waypoint Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansWaypoint Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.